Skip to content
MARKETS / NASDAQ / CLOV
NASDAQ · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP

Clover Health Investments, Corp. CLOV

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.9B
▲ 40.3% YoY
$-85.5M
$-69.0M
▼ 307.2% YoY
In brief

What this company does

Clover Health offers Preferred Provider Organization and Health Maintenance Organization Medicare Advantage plans that incorporate its Clover Assistant software platform. Clover Health's proprietary software platform, Clover Assistant, which is licensed externally as Counterpart Assistant, is a cloud-based software platform that curates data from over 100 sources and provides physicians with data-driven insights and personalized care recommendations for patients. At January 1, 2026, the company operated its Medicare Advantage plans in five states and 203 counties. At December 31, 2025, the company had 724 employees, of whom approximately 93% were in the U.S. and 6% in Hong Kong, with the remainder dispersed across various countries. Clover Health operates as a remote first company and does not maintain a headquarters. Clover Health was incorporated on October 18, 2019 as a special purpose acquisition company and Cayman Islands exempted company under the name Social Capital Hedosophia Holdings Corp. III, which completed its initial public offering on April 24, 2020 and, on January 7, 2021, consummated a business combination with Clover Health Investments, Corp. and changed its name to Clover Health Investments, Corp.

Written from the business description in CLOVER HEALTH INVESTMENTS, CORP. /DE's annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth
USD 1.9B
Revenue, FY2025 · full 7-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.9 · Net income -0.1
0.8B1.6B-0.2B-0.4B2019202020212022202320242025
Compound annual growth
+20.6%
+23.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +23.4% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−4 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -4.4% · Net -4.4%
-20%-40%-60%2019202020212022202320242025
ROE
FY2023 · ROE -61.4%
-20%-40%-60%2019202020212022202320242025

Cash & shareholders
USD 17.2M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -69.0
20M-100M-200M2019202020212022202320242025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 17.2
-100M-200M2019202020212022202320242025

USD 17.2M in buybacks went back to shareholders in a year without profit.

Total assetsUSD 541.0M
CashUSD 78.3M
DepositsUSD 14.6M
Current ratio1.47×

Not available: we don't have the total debt figure for this period.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B1.91.41.31.11.50.70.5
Operating income $B−0.1−0.0−0.2−0.3−0.6−0.1−0.2
EBITDA $B−0.1−0.0−0.2−0.3−0.6−0.1−0.2
Income tax $B0.00.00.00.00.00.00.0
Net income $B−0.1−0.0−0.2−0.3−0.6−0.1−0.4
Free cash flow $B−0.10.0−0.1−0.2−0.3−0.1−0.2
EPS, diluted $··−0.44−0.71−1.42−1.54−4.14
Dividend / sh $·······
Payout %·······
ROE %··−61.4−76.9···

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 26 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 50 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityHospital & Medical Service Plans
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image